Kevin Lalande

Track

Insider profile

Currently holds positions in Lumos Pharma Inc and Molecular Templates Inc

Performance

Overall performance
3.8
Performance over holding periods
3.8
30 days 90 days 120 days
Average return 12% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
5 60% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Director Lumos Pharma Inc March 18, 2020 -
Independent Director Molecular Templates Inc Aug. 1, 2017 -
Kevin Lalande's trades of Molecular Templates Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-06-21 2022-06-15
B Purchase
8,751 +11.4%
137.16
US$2,322,524 		8,751 +11.4% 137.16 US$2,322,524
2022-06-21 2022-06-14
B Purchase
73,364 -28.0%
203.84
US$1,442,700 		73,364 -28.0% 203.84 US$1,442,700
2022-06-21 2022-06-13
B Purchase
66,210 +25.4%
373.91
US$3,740,056 		66,210 +25.4% 373.91 US$3,740,056
2020-09-18 2020-09-16
S Sale
500,000 -7.6%
13.05
US$6,525,000 		500,000 -7.6% 13.05 US$6,525,000
2020-05-22 2020-05-20
S Sale
300,000 -4.3%
16.51
US$4,953,000 		300,000 -4.3% 16.51 US$4,953,000